WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Andrik Doubek (B13), Periosteal Apposition of Bone Heightened levels manifest as Linear Growth, IL-1 Inhibit Release of GnRH, DHEA May Become Androstenedione, Testosterone May Become 5- Alpha Dihydrotestosterone (DHT), Estriadol Inhibit release of LH, DHEA 17 Beta HSD Androstenediol, Testosterone Measured as Total Testosterone, Andrik Doubek presents with Height of 53 Inches, Androstenediol 3 Beta HSD Testosterone, HPA Axis Begins at Hypothalamus, Tanner Stage III Due to High Levels of 5- Alpha Dihydrotestosterone (DHT), 17 alpha- hydroxyprogesterone Level levels post ACTH Stimulatoin were 2500 ng/dl (within non-classic range), Glucocorticoid Therapy Inhibits release of CRH, Estriadol Increases Bone Formation, Inhibin B Inhibit Release of FSH, Electrolytes Confirm non-classic diagnosis of Precocious Pseudopuberty, LH Stimulates Leydig Cells, Abnormal Genital Maturation including Dark, Coarse, Curly Pubic Hair, Andrik Doubek is a Male, Two SD Above Normal On His Growth Chart a result of overstimulated Linear Growth